ÂÜÀòÂÒÂ×

T. Scott Reid currently serves as Vice President and Global Head of Companion Diagnostics at Discovery Life Sciences, focusing on developing diagnostic solutions for Biopharma clients in support of clinical trials and commercial launch. Prior to this role, T. Scott Reid held various leadership positions, including Vice President and Global Head of Diagnostics at SOPHiA GENETICS, and multiple roles at NeoGenomics Laboratories, emphasizing companion diagnostics and strategic alliances. Previous experience also includes business development at Covance and LabCorp Clinical Trials, where T. Scott Reid specialized in companion diagnostics and biomarker solutions. T. Scott Reid's educational background includes an MBA from Duke University's Fuqua School of Business, a PhD in Biochemistry from Duke University, and a BScH in Biochemistry from Queen's University.